The Centers for Medicare and Medicaid Services (CMS) recently advanced a series of policy actions aimed at strengthening program integrity and reducing fraud, waste, and abuse, or FWA for short, across Medicare and Medicaid.
While these initiatives reflect the Trump Administration’s commitment to safeguarding taxpayer dollars, some healthcare providers and industry stakeholders caution that these proposals could create unintended consequences for legitimate providers and patient access to care.
One such proposal would expand the CMS authority to deny or revoke Medicare enrollment for providers suspected of fraudulent activity. The agency argues that broader oversight would enable it to identify and remove bad actors before fraudulent billing can occur, reinforcing the integrity of the Medicare program. Enhanced enrollment screening has long been viewed as an important tool in combating healthcare fraud, but costs federal programs billions of dollars annually.
However, provider organizations have expressed concern that the proposal’s expanded enforcement powers could sweep compliant practitioners into lengthy administrative reviews or enrollment disputes. Critics argue that while aggressive oversight may increase scrutiny, it may do little to deter sophisticated fraud schemes while creating additional administrative burdens for providers that already face complex regulatory requirements. Healthcare groups are encouraging CMS to ensure that any new authority includes appropriate due process protections and clear enforcement standards.
CMS has also demonstrated its willingness to take direct financial action. As part of the administration’s broader campaign against FWA, the agency recently halted over $1B in Medicaid payments to California and Minnesota. According to CMS, financial reviews identified unsupported claims and spending growth that significantly exceeded national trends, prompting the payment suspension while further investigation is conducted. The move indicates a more hardline federal approach to Medicaid oversight and highlights the administration’s focus on ensuring that federal healthcare dollars are used appropriately.
While supporters view these actions as necessary to strengthen accountability, state officials and healthcare groups may face operational and financial challenges if funding disruptions affect ongoing care delivery. The balance between protecting public funds and maintaining continuity of patient care will likely remain a central issue as additional audits and reviews are undertaken.
Another area attracting significant attention is the CMS latest proposal to prohibit Medicare reimbursement for remote patient monitoring, or RPM, services when they are delivered by third-party vendors. RPM has become an increasingly important component of chronic disease management, allowing clinicians to monitor patients outside traditional care settings and intervene earlier when health conditions worsen. Third-party tech vendors frequently provide the infrastructure that enables these programs, particularly for smaller providers and health systems serving rural communities.
Healthcare organizations and trade associations say that eliminating reimbursement for vendor-supported RPM could substantially reduce access to these services, especially in underserved areas where providers rely on outside partners to deploy monitoring technology. Stakeholders contend that rather than preventing fraud, the proposal could inadvertently discourage innovation and limit the adoption of proven digital health solutions that improve patient outcomes and reduce hospitalizations.
Interestingly, Congress appears to be approaching RPM differently. Just two days after CMS released its proposed rule, a House committee approved legislation designed to expand and protect access to RPM technologies. The timing suggests a potential policy divide between the administration’s efforts to tighten oversight and lawmakers’ interest in preserving access to emerging healthcare tech tools that support value-based care.
Taken together, these developments illustrate the ongoing challenge facing federal policymakers: That is, combating fraud–-a key issue for this administration––while preserving access to high-quality healthcare services.
As CMS continues to refine its proposals through rulemaking processes, providers, technology companies, and lawmakers will likely remain engaged in shaping policies that both strengthen program integrity and support patient care.
References:
- https://www.modernhealthcare.com/politics-regulation/mh-cms-medicare-enrollment-fraud-rule/
- https://www.axios.com/2026/07/21/trump-medicaid-freeze-california-minnesota
- https://www.beckershospitalreview.com/healthcare-information-technology/telehealth/health-systems-trade-groups-oppose-cms-proposed-remote-patient-monitoring-ban/
